Results 261 to 270 of about 98,896 (358)

Protectin D1 and maresin 1 attenuate airway hyperreactivity induced by IL‐13 in human isolated small bronchi

British Journal of Pharmacology, Volume 183, Issue 9, Page 2049-2060, May 2026.
Background and Purpose Interleukin (IL)‐13 is implicated in airway hyperreactivity (AHR), a key feature of asthma. We explored the potential anti‐AHR activity of selected specialised pro‐resolving mediators (SPMs) in IL‐13‐induced AHR models, using human bronchial smooth muscle cells (BSMCs) and human isolated bronchi.
Willem Abma, Sven‐Erik Dahlén, Craig E. Wheelock, Mikael Adner, Mamdoh Al‐Amerie, Erik Sachs, Kasra Vali Jalali, Leonardo De Maria, Henric Olsson, Jesper Säfholm   +9 more
wiley   +1 more source

The Activity of Protectin DX, 17 HDHA and Leukotriene B4 Is Correlated with Interleukin-1β (IL-1β) and Interleukin-1 Receptor Antagonist (IL-1Ra) in the Early Subacute Phase of Stroke. [PDF]

Int J Mol Sci
Kotlega D, Drozd A, Zembron-Lacny A, Morawin B, Ryterska K, Szczuko M.   +5 more
europepmc   +1 more source

Influence of the lysosomal elastase inhibitor eglin on development of interstitial lung edema in E. coli bacteremia in pigs [PDF]

, 1987
Jochum, Marianne, Redl, H., Schlag, G., Siebeck, Matthias, Thetter, O., Welter, H. F.   +5 more
core  

Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review

Radhika Sood, Shailendra Anoopkumar‐Dukie, Santosh Rudrawar, Susan Hall   +3 more
openalex   +1 more source

Bruton tyrosine kinase (Btk) in neutrophils is indispensable for initiating and maintaining skin inflammation in a model of pemphigoid diseases

British Journal of Pharmacology, Volume 183, Issue 10, Page 2446-2463, May 2026.
Background and Purpose Bruton tyrosine kinase (Btk) is essential for B cell function. Its role in myeloid cells is less understood. Greater insights into Btk significance in myeloid cells are needed to evaluate its potential as a therapeutic target during the effector phase of antibody‐induced autoimmune diseases, where inhibiting autoantibody ...
Henning Olbrich, Paul Schilf, Sripriya Murthy, Sina Gonther, Mareike Neumann, Christoph M. Hammers, Jasper N. Pruessmann, Christian D. Sadik   +7 more
wiley   +1 more source

Xiebai San Alleviates Allergic Pulmonary Inflammation by Modulating Arachidonic Acid Metabolism. [PDF]

Pharmaceuticals (Basel)
Yue X, Han J, Pan C, Zhang Y, Liu S, Gao F, Zhao Y, Wu J, Wang Y, Cheng X, Liang A.   +10 more
europepmc   +1 more source

Mechanism of Cardiac Arrest in Fatal Anaphylaxis

Clinical &Experimental Allergy, Volume 56, Issue 5, Page 506-515, May 2026.
This population‐based retrospective cohort study of clinical deterioration in anaphylaxis deaths identifies bronchospasm as the preponderant cause of cardiac arrest, especially in food and drug allergen exposures. The clinical implication is that anaphylaxis guidelines require appropriate emphasis on respiratory involvement and treatment to prevent ...
Ben A. McKenzie, Stuart D. Marshall, Lena A. Sanci, Catriona Moynihan, Chris Selman, Jo A. Douglass   +5 more
wiley   +1 more source

High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy. [PDF]

Laryngoscope Investig Otolaryngol
Kamimura S, Ishitani K, Morozumi R, Fujii T, Kitamura Y.   +4 more
europepmc   +1 more source

Autoantibodies against cerebral gray matter in patients with insulin dependant diabetes mellitus [PDF]

, 1990
Kömpf, D., Schaper, J., Schuhose, C., Scriba, Peter Christian, Stöcker, W., Vieregge, P.   +5 more
core  

A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms [PDF]

Nastaran Kordjazy, Shahideh Amini
openalex   +1 more source